| A | B | C | D | E | F | G | H | I | J | K | L | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ||||||||||||
| 2 | Name | Indication | Approval | MOA | Admin | Economics | IP | Price USD | 38.93 | |||
| 3 | Darzalex (daratumumab) | Multiple Myeloma | CD38 mab | J&J | Price DKK | 2703 | ||||||
| 4 | Tivdak (tisotumab vedotin) | Cervical Cancer | TF | SGEN | Shares | 65.829282 | Q322 | |||||
| 5 | Kesimpta (ofatumumab) | NVS | MC USD | 25627.3394826 | ||||||||
| 6 | Tepezza (teprotumumab) | HZNP/RO | MC DKK | 177936.549246 | ||||||||
| 7 | Rybrevant (amivantamab) | JNJ | Cash DKK | 23943 | Q322 | |||||||
| 8 | Tecvayli (teclistamab) | JNJ | Debt DKK | 0 | Q322 | |||||||
| 9 | EV DKK | 153993.549246 | ||||||||||
| 10 | epcoritamab | CD20xCD3 mab | ABBV | |||||||||
| 11 | GEN1046/BNT311 | PD-L1/4-1BB | BNTX | |||||||||
| 12 | GEN1042/BNT312 | CD40x4-1BB | BNTX | |||||||||
| 13 | GEN3009 | CD37 | ABBV | |||||||||
| 14 | GEN3014 | CD38 Hexabody | JNJ |